Blood Clot Treatment in Cancer Patients
Links shared publicly online about this topic.
- 161total visits
Blood Clot Treatment in Cancer Patients
View full resource at medindia.net
Tags: Cancer, Thrombotic Event, Blood Clot, Drug, Anti-Clotting Medication, Anticoagulant
Most Recently Shared on July 8, 2011 at 5:45 pm By:
RT @mtmdphd: IVC filter no benefit when added to fondaparinux, http://is.gd/juuqBv
Blood Clot Risk for Outpatients Needs More Attention: Study - MSN Health - Cancer
health.msn.com — “Researchers created tool to measure patient risk following surgery” View full resource at health.msn.com
Most Recently Shared on April 27, 2012 at 6:36 pm By:
Blood Clot Risk for Outpatients Needs More Attention: Study: http://t.co/TDr8cxan
Researchers discover a DNA marker that indicates if ovarian cancer treatment will be successful
eurekalert.org — “Researchers and doctors at the North Shore-LIJ Health System and the have discovered that blood can help determine the best treatment plan for patients with ovarian cancer.” View full resource at eurekalert.org
Most Recently Shared on April 3, 2012 at 8:30 pm By:
Researchers discover a #DNA marker that indicates if ovarian #cancer treatment will be successful. http://t.co/jniQBZqa
Tremelimumab Shows Promise in Treatment of Liver Cancer
aacr.org — “Tumor burden reduction and disease stabilization occurred in some cases. Tremelimumab also reduced blood levels of hepatitis C virus. CHICAGO — Tremelimumab treatment stabilized patients with advanced hepatocellular carcinoma due to chronic hepatitis C infection for more than 12 months, according to data presented at the AACR Annual Meeting 2012, held here March 31 - April 4.Researchers evaluated 21 patients treated with tremelimumab intravenously at a dose of 15 mg/kg every 90 days for ab” View full resource at aacr.org
Most Recently Shared on April 3, 2012 at 12:29 am By:
Dr. P. D Tapp Health Executive, PhD, and Doctor
Tremelimumab Shows Promise in Treatment of Liver Cancer: http://t.co/tATE1IqK
Cancer cells in blood predict chances of survival and can help target breast cancer treatment
medicalxpress.com — “Detecting the presence of circulating tumour cells (CTCs) in the blood of women with early breast cancer after surgery but before the start of chemotherapy can provide useful information about their chances of surviving the disease. CTCs are cancer cells which are detectable in patients with a solid ...” View full resource at medicalxpress.com
Most Recently Shared on March 22, 2012 at 9:12 am By:
PhysOrg Health News Health News
Cancer cells in blood predict chances of survival and can help target breast cancer treatment http://t.co/fvdKdqBf
Cancer patients: Higher risk of blood clot - UPI.com
upi.com — “Patients with cancer have an increased risk of deep-vein thrombosis -- blood clots -- but only 16 percent knew of the risk, a U.S. survey indicated.” View full resource at upi.com
Most Recently Shared on March 14, 2012 at 9:09 pm By:
ASH Health Organization and Hematology
Survey: Most #cancer patients unaware of #DVT risk http://t.co/r38o9xVs via @upi_top
Cancer patients: Higher risk of blood clot - UPI.com
upi.com — “Patients with cancer have an increased risk of deep-vein thrombosis -- blood clots -- but only 16 percent knew of the risk, a U.S. survey indicated.” View full resource at upi.com
Most Recently Shared on March 13, 2012 at 6:31 am By:
Cancer patients: Higher risk of blood clot: NEW YORK, March 12 (UPI) -- Patients with cancer have an increased r... http://t.co/GHJjBIwU
Myeloma treatment regimen shows promise for AL amyloidosis - National Cancer Institute
cancer.gov — “Two studies published in Blood, the Journal of the American Society of Hematology (ASH), demonstrate preliminary success of an effective multiple myeloma (MM) regimen in patients with AL amyloidosis, a rare and devastating blood disease that results in de” View full resource at cancer.gov
Most Recently Shared on February 14, 2012 at 6:52 pm By:
Study by @MayoClinic finds powerful #myeloma treatment regimen shows promise for AL amyloidosis http://t.co/jhafn5Tu #cancer
Clopidogrel With Aspirin Doesn't Prevent More Small Strokes, May Increase Risk Of Bleeding, Death
medicalnewstoday.com — “The anti-blood clot regimen that adds the drug clopidogrel (Plavix) to aspirin treatment is unlikely to prevent recurrent strokes and may increase the risk of bleeding and death in patients with s” View full resource at medicalnewstoday.com
Most Recently Shared on February 6, 2012 at 10:05 am By:
MNT Cardiovascular Health News
Clopidogrel With Aspirin Doesn't Prevent More Small Strokes, May Increase Risk Of Bleeding, Death http://t.co/LoqV7ksR #cardiovascular
New Device Removes Stroke-Causing Blood Clots Better Than Standard Treatment
medicalnewstoday.com — “An experimental device for removing blood clots in stroke patients dramatically outperformed the standard mechanical treatment, according to research presented by UCLA Stroke Center director Dr. J” View full resource at medicalnewstoday.com
Most Recently Shared on February 6, 2012 at 9:06 am By:
MNT Medical Devices Health News
New Device Removes Stroke-Causing Blood Clots Better Than Standard Treatment http://t.co/pLI4yzef #medicaldevices
Voraxaze receives FDA approval for treatment of toxic methotrexate levels
news-medical.net — “The U.S. Food and Drug Administration today approved Voraxaze (glucarpidase) to treat patients with toxic levels of methotrexate in their blood due to kidney failure.” View full resource at news-medical.net
Most Recently Shared on January 18, 2012 at 5:23 am By:
News-Medical.Net Oncology and Health News
Oncology News: Voraxaze receives FDA approval for treatment of toxic methotrexate levels: The U.S. Food and Drug... http://t.co/4CaPKaGy
Newcastle Scientists Find Genetic Key To Why Some Cancer Patients Don't Respond To Treatment
medicalnewstoday.com — “In a study funded by the charity Leukemia & Lymphoma Research published in the leukemia journal Blood in January, scientists from Newcastle University have discovered a gene variation that” View full resource at medicalnewstoday.com
Most Recently Shared on January 10, 2012 at 11:42 pm By:
Researchers identify CD95 gene preventing Acute Promyelocytic Leukemia patients from responding to treatmt http://t.co/qG0vyZ3S
Outpatients Experience The Most Cancer-Related Blood Clots
medicalnewstoday.com — “In a study of nearly 18,000 cancer patients, University of Rochester Medical Center researchers found that when blood clots develop - a well-known and serious complication of cancer treatment - 78” View full resource at medicalnewstoday.com
Most Recently Shared on December 13, 2011 at 11:05 am By:
Outpatients Experience The Most Cancer-Related Blood Clots http://t.co/H31KEKG4 #cancer
Cancer Outpatients at Greater Risk for Blood Clots - iVillage
ivillage.com — “MONDAY, Dec. 12 (HealthDay News) -- Cancer patients receiving chemotherapy most often develop blood clots after they are discharged from the hospital, according to a large new study. Efforts to prevent this common and potentially life-threate” View full resource at ivillage.com
Most Recently Shared on December 13, 2011 at 1:04 am By:
Cancer Outpatients at Greater Risk for Blood Clots http://t.co/3vkpyCJz
Hemophilia B - Single Gene Therapy Treatment Offers Significant Improvement
medicalnewstoday.com — “Patients with hemophilia B experienced considerable improvements and fewer injections with clotting factor to reduce bleeding after receiving just one treatment with gene therapy, researchers from” View full resource at medicalnewstoday.com
Most Recently Shared on December 10, 2011 at 8:05 pm By:
Hemophilia B - Single Gene Therapy Treatment Offers Significant Improvement http://t.co/1RVC3T8U #blood #hematology
Novel Monoclonal Antibody Offers Potential Treatment for Tumors Resistant to VEGF Therapy
aacr.org — “Shutting down the ALK-1 receptor inhibits the VEGF pathway. Response seen in patients who had used antiangiogenic therapy. VEGF therapies might work best in combination. SAN FRANCISCO — Despite the widespread use of current antiangiogenic cancer therapies, many tumors escape this blockade, which is designed to shut down growth of new blood vessels that feed tumors and spread cancer cells. Now, a study reported at the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer The” View full resource at aacr.org
Most Recently Shared on November 22, 2011 at 5:57 am By:
Paul Cacciatore Patient Advocate
Novel Monoclonal Antibody PF-03446962 Offers Potential Treatment 4 Tumors Resistant 2 VEGF Therapy 2011 AACR-NCI-EORTC http://t.co/mI89ZZq6
Advertisement
